Marketing-authorisation holder · United States
Mayne Pharma
15 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
15 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
15 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANNOVERA0.013mg/24hr; 0.15mg/24hr · Ring | Ethinyl estradiol, Segesterone | United States | Marketed | 2018 |
| BIJUVA0.5mg; 100mg | 1mg; 100mg · Capsule | Estradiol, Progesterone | United States | Marketed | 2018 |
| DORYX100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG BASE | 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons · Tablet, delayed release | Doxycycline | United States | Not marketed | 2005 |
| DORYX100mg base | 75mg base · Capsule, delayed release | Doxycycline | United States | Not marketed | 1985 |
| DORYX MPC120MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 60MG BASE · Tablet, delayed release | Doxycycline | United States | Marketed | 2005 |
| EPSOLAY5% · Cream | Benzoyl peroxide | United States | Marketed | 2022 |
| FABIOR0.1% · Aerosol, foam | Tazarotene | United States | Marketed | 2012 |
| IMVEXXY0.004mg | 0.01mg · Insert | Estradiol | United States | Marketed | 2018 |
| LEXETTE0.05% · Aerosol, foam | Ulobetasol | United States | Not marketed | 2018 |
| NEXTSTELLIS3mg; 14.2mg · Tablet | Drospirenone, Estetrol | United States | Marketed | 2021 |
| RHOFADE1% · Cream | Oxymetazoline | United States | Marketed | 2017 |
| SORILUX0.005% · Aerosol, foam | Calcipotriene | United States | Marketed | 2010 |
| TOLSURA65mg · Capsule | Itraconazole | United States | Marketed | 2018 |
| TWYNEO3%; 0.1% · Cream | Benzoyl peroxide, Tretinoin | United States | Marketed | 2021 |
| ETHINYL ESTRADIOL; LEVONORGESTREL0.02mg,0.15mg; 0.025mg,0.15mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | tentative | 2017 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 15 | 14 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.